LLY - Lilly's Retevmo gains traditional approval in thyroid cancer
2024-06-12 14:39:17 ET
More on Eli Lilly
- Eli Lilly: The Road To Approval Of Donanemab Is Open
- Eli Lilly and Company (LLY) Goldman Sachs 45th Annual Global Healthcare Conference
- Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs?
- GLP-1 obesity drug coverage dropped by Blue Cross Michigan: report
- Wall Street’s most overbought stocks include NVDA, COST, LLY, and others